Clinical Trials Directory

Trials / Completed

CompletedNCT03874949

Pain After Root Canal Obturation With Sealer Containing or Not 1% Enoxolone

Comparison of Postoperative Pain After Root Canal Obturation With Sealer Containing or Not 1% Enoxolone: a Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
95 (actual)
Sponsor
ACTEON Group · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study aims to assess the efficacy of a zinc oxide eugenol sealer containing Enoxolone, a non-steroidal anti inflammatory drug (NSAID) on the pain relief after endodontic treatment. The study design is a multicenter, doubled blinded randomized controlled trial. The comparator is the equivalent zinc oxide eugenol sealer without NSAID (allocation ratio is 1:1). The conventional endodontic treatment, using gutta percha and sealer, is done. Patients assess their pain for 7 days after permanent root obturation.

Conditions

Interventions

TypeNameDescription
DEVICESEALITE RegularPatients are treated with SEALITE Regular sealer (zinc oxide eugenol sealer). The SEALITE Regular powder is mixed with SEALITE Liquid according to the manufacturer instructions and added to gutta percha in the root canal for permanent obturation. The apical obturation is assessed by a postoperative radiographic control.
DEVICESEALITE UltraPatients are treated with SEALITE Ultra sealer (zinc oxide eugenol sealer containing 1% Enoxolone). The SEALITE Ultra powder is mixed with SEALITE Liquid according to the manufacturer instructions and added to gutta percha in the root canal for permanent obturation. The apical obturation is assessed by a postoperative radiographic control.

Timeline

Start date
2019-04-02
Primary completion
2019-08-20
Completion
2019-08-20
First posted
2019-03-14
Last updated
2019-09-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03874949. Inclusion in this directory is not an endorsement.